Symbio Is Your Gastroenterology CRO
For more than 25 years, Symbio has been managing biologics, complex protocols, and chronic inflammatory conditions, giving us invaluable insights into gastroenterology indications driven by:
- Genetic overlaps in skin and gut inflammation
- Shared pathways like TNF-α, IL-23, and JAK/STAT
- Barrier dysfunction and microbiome dysbiosis
We take our proven expertise in immune-mediated inflammatory diseases and translate it directly into high-performing gastroenterology trials — accelerating development, reducing risk, and making a greater impact on patient outcomes.
Our Gastroenterology Research Experience
From common to rare and complex conditions, Symbio brings specialized expertise across gastrointestinal indications:
Eosinophilic & Allergic Disorders
- Eosinophilic esophagitis (EoE)
- Eosinophilic Gastroenteritis
Functional & Motility Disorders
- Chronic idiopathic constipation
- Functional dyspepsia
- Gastroparesis
Gastrointestinal Disorders
- Barrett’s esophagus
- Gastritis
- Gastroesophageal cancer
- Gastroesophageal Reflux Disease (GERD)
Inflammatory Bowel Diseases (IBD)
- Crohn’s disease
- Ulcerative colitis
- Ulcerative proctitis
How Does Symbio Enhance Gastroenterology Trials?
Symbio works as your true gastroenterology research partner, meeting milestones faster and delivering quality data with:
